共 50 条
- [21] Efficacy and safety of nelfinavir in asymptomatic and mild COVID-19 patients: a structured summary of a study protocol for a multicenter, randomized controlled trial[J]. TRIALS, 2021, 22 (01)Hosogaya, Naoki论文数: 0 引用数: 0 h-index: 0机构: Nagasaki Univ Hosp, Clin Res Ctr, Nagasaki, Japan Nagasaki Univ Hosp, Dept Resp Med, Nagasaki, Japan Nagasaki Univ Hosp, Clin Res Ctr, Nagasaki, JapanMiyazaki, Taiga论文数: 0 引用数: 0 h-index: 0机构: Nagasaki Univ Hosp, Dept Resp Med, Nagasaki, Japan Nagasaki Univ, Dept Infect Dis, Grad Sch Biomed Sci, 1-7-1 Sakamoto, Nagasaki 8528501, Japan Nagasaki Univ Hosp, Clin Res Ctr, Nagasaki, JapanFukushige, Yuri论文数: 0 引用数: 0 h-index: 0机构: Nagasaki Univ Hosp, Clin Res Ctr, Nagasaki, Japan Nagasaki Univ Hosp, Dept Hosp Pharm, Nagasaki, Japan Nagasaki Univ Hosp, Clin Res Ctr, Nagasaki, JapanTakemori, Sachiko论文数: 0 引用数: 0 h-index: 0机构: Nagasaki Univ Hosp, Clin Res Ctr, Nagasaki, Japan Nagasaki Univ Hosp, Clin Res Ctr, Nagasaki, JapanMorimoto, Shinpei论文数: 0 引用数: 0 h-index: 0机构: Nagasaki Univ Hosp, Clin Res Ctr, Nagasaki, Japan Nagasaki Univ Hosp, Clin Res Ctr, Nagasaki, JapanYamamoto, Hiroshi论文数: 0 引用数: 0 h-index: 0机构: Nagasaki Univ Hosp, Clin Res Ctr, Nagasaki, Japan Nagasaki Univ Hosp, Clin Res Ctr, Nagasaki, JapanHori, Makoto论文数: 0 引用数: 0 h-index: 0机构: Chiba Univ Hosp, Clin Res Ctr, Chiba, Japan Nagasaki Univ Hosp, Clin Res Ctr, Nagasaki, JapanKurokawa, Tomoya论文数: 0 引用数: 0 h-index: 0机构: Chiba Univ Hosp, Clin Res Ctr, Chiba, Japan Nagasaki Univ Hosp, Clin Res Ctr, Nagasaki, JapanKawasaki, Yohei论文数: 0 引用数: 0 h-index: 0机构: Chiba Univ Hosp, Clin Res Ctr, Chiba, Japan Nagasaki Univ Hosp, Clin Res Ctr, Nagasaki, JapanHanawa, Michiko论文数: 0 引用数: 0 h-index: 0机构: Chiba Univ Hosp, Clin Res Ctr, Chiba, Japan Nagasaki Univ Hosp, Clin Res Ctr, Nagasaki, JapanFujii, Yasuhisa论文数: 0 引用数: 0 h-index: 0机构: Chiba Univ Hosp, Clin Res Ctr, Chiba, Japan Nagasaki Univ Hosp, Clin Res Ctr, Nagasaki, JapanHanaoka, Hideki论文数: 0 引用数: 0 h-index: 0机构: Chiba Univ Hosp, Clin Res Ctr, Chiba, Japan Nagasaki Univ Hosp, Clin Res Ctr, Nagasaki, JapanIwami, Shingo论文数: 0 引用数: 0 h-index: 0机构: Kyushu Univ, Fac Sci, Dept Biol, Fukuoka, Japan Nagasaki Univ Hosp, Clin Res Ctr, Nagasaki, JapanWatashi, Koichi论文数: 0 引用数: 0 h-index: 0机构: Natl Inst Infect Dis, Dept Virol 2, Tokyo, Japan Natl Inst Infect Dis, Res Ctr Drug & Vaccine Dev, Tokyo, Japan Nagasaki Univ Hosp, Clin Res Ctr, Nagasaki, JapanYamagoe, Satoshi论文数: 0 引用数: 0 h-index: 0机构: Natl Inst Infect Dis, Dept Chemotherapy & Mycoses, Tokyo, Japan Nagasaki Univ Hosp, Clin Res Ctr, Nagasaki, JapanMiyazaki, Yoshitsugu论文数: 0 引用数: 0 h-index: 0机构: Natl Inst Infect Dis, Dept Chemotherapy & Mycoses, Tokyo, Japan Nagasaki Univ Hosp, Clin Res Ctr, Nagasaki, JapanWakita, Takaji论文数: 0 引用数: 0 h-index: 0机构: Natl Inst Infect Dis, Dept Virol 2, Tokyo, Japan Nagasaki Univ Hosp, Clin Res Ctr, Nagasaki, JapanIzumikawa, Koichi论文数: 0 引用数: 0 h-index: 0机构: Nagasaki Univ, Dept Infect Dis, Grad Sch Biomed Sci, 1-7-1 Sakamoto, Nagasaki 8528501, Japan Nagasaki Univ Hosp, Clin Res Ctr, Nagasaki, JapanYanagihara, Katsunori论文数: 0 引用数: 0 h-index: 0机构: Nagasaki Univ Hosp, Dept Lab Med, Nagasaki, Japan Nagasaki Univ Hosp, Clin Res Ctr, Nagasaki, Japan论文数: 引用数: h-index:机构:Kohno, Shigeru论文数: 0 引用数: 0 h-index: 0机构: Nagasaki Univ Hosp, Dept Resp Med, Nagasaki, Japan Nagasaki Univ Hosp, Clin Res Ctr, Nagasaki, Japan
- [22] Safety and Efficacy of Ixekizumab and Antiviral Treatment for Patients with COVID-19: A structured summary of a study protocol for a Pilot Randomized Controlled Trial[J]. Trials, 21Panpan Liu论文数: 0 引用数: 0 h-index: 0机构: Central South University,The Department of Dermatology, Xiangya HospitalZhijun Huang论文数: 0 引用数: 0 h-index: 0机构: Central South University,The Department of Dermatology, Xiangya HospitalMingzhu Yin论文数: 0 引用数: 0 h-index: 0机构: Central South University,The Department of Dermatology, Xiangya HospitalChun Liu论文数: 0 引用数: 0 h-index: 0机构: Central South University,The Department of Dermatology, Xiangya HospitalXiang Chen论文数: 0 引用数: 0 h-index: 0机构: Central South University,The Department of Dermatology, Xiangya HospitalPinhua Pan论文数: 0 引用数: 0 h-index: 0机构: Central South University,The Department of Dermatology, Xiangya HospitalYehong Kuang论文数: 0 引用数: 0 h-index: 0机构: Central South University,The Department of Dermatology, Xiangya Hospital
- [23] Safety and Efficacy of Ixekizumab and Antiviral Treatment for Patients with COVID-19: A structured summary of a study protocol for a Pilot Randomized Controlled Trial[J]. TRIALS, 2020, 21 (01)Liu, Panpan论文数: 0 引用数: 0 h-index: 0机构: Cent South Univ, Xiangya Hosp, Dept Dermatol, Changsha, Peoples R China Hunan Key Lab Skin Canc & Psoriasis, Changsha, Peoples R China Cent South Univ, Xiangya Hosp, Hunan Engn Res Ctr Skin Hlth & Dis, 87 XiangYa Rd, Changsha 410008, Hunan, Peoples R China Cent South Univ, Xiangya Hosp, Dept Dermatol, Changsha, Peoples R ChinaHuang, Zhijun论文数: 0 引用数: 0 h-index: 0机构: Cent South Univ, Xiangya Hosp 3, Ctr Clin Pharmacol, Changsha, Peoples R China Cent South Univ, Xiangya Hosp, Dept Dermatol, Changsha, Peoples R ChinaYin, Mingzhu论文数: 0 引用数: 0 h-index: 0机构: Cent South Univ, Xiangya Hosp, Dept Dermatol, Changsha, Peoples R China Hunan Key Lab Skin Canc & Psoriasis, Changsha, Peoples R China Cent South Univ, Xiangya Hosp, Hunan Engn Res Ctr Skin Hlth & Dis, 87 XiangYa Rd, Changsha 410008, Hunan, Peoples R China Cent South Univ, Xiangya Hosp, Dept Dermatol, Changsha, Peoples R ChinaLiu, Chun论文数: 0 引用数: 0 h-index: 0机构: Cent South Univ, Xiangya Hosp 3, Dept Resp & Crit Care Med, Changsha, Peoples R China Cent South Univ, Xiangya Hosp, Dept Dermatol, Changsha, Peoples R ChinaChen, Xiang论文数: 0 引用数: 0 h-index: 0机构: Cent South Univ, Xiangya Hosp, Dept Dermatol, Changsha, Peoples R China Hunan Key Lab Skin Canc & Psoriasis, Changsha, Peoples R China Cent South Univ, Xiangya Hosp, Hunan Engn Res Ctr Skin Hlth & Dis, 87 XiangYa Rd, Changsha 410008, Hunan, Peoples R China Cent South Univ, Xiangya Hosp, Gerontol Ctr, Changsha, Peoples R China Cent South Univ, Xiangya Hosp, Dept Dermatol, Changsha, Peoples R ChinaPan, Pinhua论文数: 0 引用数: 0 h-index: 0机构: Cent South Univ, Xiangya Hosp, Resp Dept, 87 XiangYa Rd, Changsha 410008, Hunan, Peoples R China Cent South Univ, Xiangya Hosp, Dept Dermatol, Changsha, Peoples R ChinaKuang, Yehong论文数: 0 引用数: 0 h-index: 0机构: Cent South Univ, Xiangya Hosp, Dept Dermatol, Changsha, Peoples R China Hunan Key Lab Skin Canc & Psoriasis, Changsha, Peoples R China Cent South Univ, Xiangya Hosp, Hunan Engn Res Ctr Skin Hlth & Dis, 87 XiangYa Rd, Changsha 410008, Hunan, Peoples R China Cent South Univ, Xiangya Hosp, Dept Dermatol, Changsha, Peoples R China
- [24] Efficacy and safety of nelfinavir in asymptomatic and mild COVID-19 patients: a structured summary of a study protocol for a multicenter, randomized controlled trial[J]. Trials, 22Naoki Hosogaya论文数: 0 引用数: 0 h-index: 0机构: Nagasaki University Hospital,Clinical Research CenterTaiga Miyazaki论文数: 0 引用数: 0 h-index: 0机构: Nagasaki University Hospital,Clinical Research CenterYuri Fukushige论文数: 0 引用数: 0 h-index: 0机构: Nagasaki University Hospital,Clinical Research CenterSachiko Takemori论文数: 0 引用数: 0 h-index: 0机构: Nagasaki University Hospital,Clinical Research CenterShinpei Morimoto论文数: 0 引用数: 0 h-index: 0机构: Nagasaki University Hospital,Clinical Research CenterHiroshi Yamamoto论文数: 0 引用数: 0 h-index: 0机构: Nagasaki University Hospital,Clinical Research CenterMakoto Hori论文数: 0 引用数: 0 h-index: 0机构: Nagasaki University Hospital,Clinical Research CenterTomoya Kurokawa论文数: 0 引用数: 0 h-index: 0机构: Nagasaki University Hospital,Clinical Research CenterYohei Kawasaki论文数: 0 引用数: 0 h-index: 0机构: Nagasaki University Hospital,Clinical Research CenterMichiko Hanawa论文数: 0 引用数: 0 h-index: 0机构: Nagasaki University Hospital,Clinical Research CenterYasuhisa Fujii论文数: 0 引用数: 0 h-index: 0机构: Nagasaki University Hospital,Clinical Research CenterHideki Hanaoka论文数: 0 引用数: 0 h-index: 0机构: Nagasaki University Hospital,Clinical Research CenterShingo Iwami论文数: 0 引用数: 0 h-index: 0机构: Nagasaki University Hospital,Clinical Research CenterKoichi Watashi论文数: 0 引用数: 0 h-index: 0机构: Nagasaki University Hospital,Clinical Research CenterSatoshi Yamagoe论文数: 0 引用数: 0 h-index: 0机构: Nagasaki University Hospital,Clinical Research CenterYoshitsugu Miyazaki论文数: 0 引用数: 0 h-index: 0机构: Nagasaki University Hospital,Clinical Research CenterTakaji Wakita论文数: 0 引用数: 0 h-index: 0机构: Nagasaki University Hospital,Clinical Research CenterKoichi Izumikawa论文数: 0 引用数: 0 h-index: 0机构: Nagasaki University Hospital,Clinical Research CenterKatsunori Yanagihara论文数: 0 引用数: 0 h-index: 0机构: Nagasaki University Hospital,Clinical Research CenterHiroshi Mukae论文数: 0 引用数: 0 h-index: 0机构: Nagasaki University Hospital,Clinical Research CenterShigeru Kohno论文数: 0 引用数: 0 h-index: 0机构: Nagasaki University Hospital,Clinical Research Center
- [25] Early antiviral treatment in outpatients with COVID-19 (FLARE): a structured summary of a study protocol for a randomised controlled trial[J]. Trials, 22Li-An K. Brown论文数: 0 引用数: 0 h-index: 0机构: UCL Institute of Immunity and Transplantation,Comprehensive Clinical Trials UnitNick Freemantle论文数: 0 引用数: 0 h-index: 0机构: UCL Institute of Immunity and Transplantation,Comprehensive Clinical Trials UnitJudy Breuer论文数: 0 引用数: 0 h-index: 0机构: UCL Institute of Immunity and Transplantation,Comprehensive Clinical Trials UnitHakim-Moulay Dehbi论文数: 0 引用数: 0 h-index: 0机构: UCL Institute of Immunity and Transplantation,Comprehensive Clinical Trials UnitKashfia Chowdhury论文数: 0 引用数: 0 h-index: 0机构: UCL Institute of Immunity and Transplantation,Comprehensive Clinical Trials UnitGemma Jones论文数: 0 引用数: 0 h-index: 0机构: UCL Institute of Immunity and Transplantation,Comprehensive Clinical Trials UnitFelicia Ikeji论文数: 0 引用数: 0 h-index: 0机构: UCL Institute of Immunity and Transplantation,Comprehensive Clinical Trials UnitAmalia Ndoutoumou论文数: 0 引用数: 0 h-index: 0机构: UCL Institute of Immunity and Transplantation,Comprehensive Clinical Trials UnitKrishneya Santhirakumar论文数: 0 引用数: 0 h-index: 0机构: UCL Institute of Immunity and Transplantation,Comprehensive Clinical Trials UnitNicky Longley论文数: 0 引用数: 0 h-index: 0机构: UCL Institute of Immunity and Transplantation,Comprehensive Clinical Trials UnitAnna M. Checkley论文数: 0 引用数: 0 h-index: 0机构: UCL Institute of Immunity and Transplantation,Comprehensive Clinical Trials UnitJoseph F. Standing论文数: 0 引用数: 0 h-index: 0机构: UCL Institute of Immunity and Transplantation,Comprehensive Clinical Trials UnitDavid M. Lowe论文数: 0 引用数: 0 h-index: 0机构: UCL Institute of Immunity and Transplantation,Comprehensive Clinical Trials Unit
- [26] Early antiviral treatment in outpatients with COVID-19 (FLARE): a structured summary of a study protocol for a randomised controlled trial[J]. TRIALS, 2021, 22 (01)Brown, Li-An K.论文数: 0 引用数: 0 h-index: 0机构: Royal Free Hosp, UCL Inst Immun & Transplantat, Pond St, London NW3 2QG, England Royal Free Hosp, UCL Inst Immun & Transplantat, Pond St, London NW3 2QG, EnglandFreemantle, Nick论文数: 0 引用数: 0 h-index: 0机构: UCL, Comprehens Clin Trials Unit, 90 High Holborn,2nd Floor, London WC1V 6LJ, England Royal Free Hosp, UCL Inst Immun & Transplantat, Pond St, London NW3 2QG, EnglandBreuer, Judy论文数: 0 引用数: 0 h-index: 0机构: UCL, Div Infect & Immun, London, England Royal Free Hosp, UCL Inst Immun & Transplantat, Pond St, London NW3 2QG, EnglandDehbi, Hakim-Moulay论文数: 0 引用数: 0 h-index: 0机构: UCL, Comprehens Clin Trials Unit, 90 High Holborn,2nd Floor, London WC1V 6LJ, England Royal Free Hosp, UCL Inst Immun & Transplantat, Pond St, London NW3 2QG, EnglandChowdhury, Kashfia论文数: 0 引用数: 0 h-index: 0机构: UCL, Comprehens Clin Trials Unit, 90 High Holborn,2nd Floor, London WC1V 6LJ, England Royal Free Hosp, UCL Inst Immun & Transplantat, Pond St, London NW3 2QG, EnglandJones, Gemma论文数: 0 引用数: 0 h-index: 0机构: UCL, Comprehens Clin Trials Unit, 90 High Holborn,2nd Floor, London WC1V 6LJ, England Royal Free Hosp, UCL Inst Immun & Transplantat, Pond St, London NW3 2QG, EnglandIkeji, Felicia论文数: 0 引用数: 0 h-index: 0机构: UCL, Comprehens Clin Trials Unit, 90 High Holborn,2nd Floor, London WC1V 6LJ, England Royal Free Hosp, UCL Inst Immun & Transplantat, Pond St, London NW3 2QG, EnglandNdoutoumou, Amalia论文数: 0 引用数: 0 h-index: 0机构: UCL, Comprehens Clin Trials Unit, 90 High Holborn,2nd Floor, London WC1V 6LJ, England Royal Free Hosp, UCL Inst Immun & Transplantat, Pond St, London NW3 2QG, EnglandSanthirakumar, Krishneya论文数: 0 引用数: 0 h-index: 0机构: UCL, Comprehens Clin Trials Unit, 90 High Holborn,2nd Floor, London WC1V 6LJ, England Royal Free Hosp, UCL Inst Immun & Transplantat, Pond St, London NW3 2QG, EnglandLongley, Nicky论文数: 0 引用数: 0 h-index: 0机构: Univ Coll London Hosp NHS Fdn Trust, Hosp Trop Dis, London, England London Sch Hyg & Trop Med, London, England Royal Free Hosp, UCL Inst Immun & Transplantat, Pond St, London NW3 2QG, EnglandCheckley, Anna M.论文数: 0 引用数: 0 h-index: 0机构: Univ Coll London Hosp NHS Fdn Trust, Hosp Trop Dis, London, England London Sch Hyg & Trop Med, London, England Royal Free Hosp, UCL Inst Immun & Transplantat, Pond St, London NW3 2QG, EnglandStanding, Joseph F.论文数: 0 引用数: 0 h-index: 0机构: UCL, UCL Great Ormond St Inst Child Hlth, Immun Sect, Infect,Inflammat, 30 Guilford St, London WC1N 1EH, England Royal Free Hosp, UCL Inst Immun & Transplantat, Pond St, London NW3 2QG, EnglandLowe, David M.论文数: 0 引用数: 0 h-index: 0机构: Royal Free Hosp, UCL Inst Immun & Transplantat, Pond St, London NW3 2QG, England Royal Free Hosp, UCL Inst Immun & Transplantat, Pond St, London NW3 2QG, England
- [27] A prospective, randomised, double blind placebo-controlled trial to evaluate the efficacy and safety of tocilizumab in patients with severe COVID-19 pneumonia (TOC-COVID): A structured summary of a study protocol for a randomised controlled trial[J]. Trials, 21Jonathan Rilinger论文数: 0 引用数: 0 h-index: 0机构: University of Freiburg,Department of Medicine III (Interdisciplinary Medical Intensive Care), Medical Center, University of Freiburg, Faculty of MedicineWinfried V. Kern论文数: 0 引用数: 0 h-index: 0机构: University of Freiburg,Department of Medicine III (Interdisciplinary Medical Intensive Care), Medical Center, University of Freiburg, Faculty of MedicineDaniel Duerschmied论文数: 0 引用数: 0 h-index: 0机构: University of Freiburg,Department of Medicine III (Interdisciplinary Medical Intensive Care), Medical Center, University of Freiburg, Faculty of MedicineAlexander Supady论文数: 0 引用数: 0 h-index: 0机构: University of Freiburg,Department of Medicine III (Interdisciplinary Medical Intensive Care), Medical Center, University of Freiburg, Faculty of MedicineChristoph Bode论文数: 0 引用数: 0 h-index: 0机构: University of Freiburg,Department of Medicine III (Interdisciplinary Medical Intensive Care), Medical Center, University of Freiburg, Faculty of MedicineDawid L. Staudacher论文数: 0 引用数: 0 h-index: 0机构: University of Freiburg,Department of Medicine III (Interdisciplinary Medical Intensive Care), Medical Center, University of Freiburg, Faculty of MedicineTobias Wengenmayer论文数: 0 引用数: 0 h-index: 0机构: University of Freiburg,Department of Medicine III (Interdisciplinary Medical Intensive Care), Medical Center, University of Freiburg, Faculty of Medicine
- [28] A prospective, randomised, double blind placebo-controlled trial to evaluate the efficacy and safety of tocilizumab in patients with severe COVID-19 pneumonia (TOC-COVID): A structured summary of a study protocol for a randomised controlled trial[J]. TRIALS, 2020, 21 (01)Rilinger, Jonathan论文数: 0 引用数: 0 h-index: 0机构: Univ Freiburg, Fac Med, Med Ctr, Dept Med 3,Interdisciplinary Med Intens Care, Hugstetterstr 55, D-79106 Freiburg, Germany Univ Freiburg, Dept Cardiol & Angiol 1, Heart Ctr Freiburg Univ, Fac Med, Freiburg, Germany Univ Freiburg, Fac Med, Med Ctr, Dept Med 3,Interdisciplinary Med Intens Care, Hugstetterstr 55, D-79106 Freiburg, GermanyKern, Winfried V.论文数: 0 引用数: 0 h-index: 0机构: Univ Freiburg, Div Infect Dis, Dept Med 2, Med Ctr,Fac Med, Freiburg, Germany Univ Freiburg, Fac Med, Med Ctr, Dept Med 3,Interdisciplinary Med Intens Care, Hugstetterstr 55, D-79106 Freiburg, GermanyDuerschmied, Daniel论文数: 0 引用数: 0 h-index: 0机构: Univ Freiburg, Fac Med, Med Ctr, Dept Med 3,Interdisciplinary Med Intens Care, Hugstetterstr 55, D-79106 Freiburg, Germany Univ Freiburg, Dept Cardiol & Angiol 1, Heart Ctr Freiburg Univ, Fac Med, Freiburg, Germany Univ Freiburg, Fac Med, Med Ctr, Dept Med 3,Interdisciplinary Med Intens Care, Hugstetterstr 55, D-79106 Freiburg, GermanySupady, Alexander论文数: 0 引用数: 0 h-index: 0机构: Univ Freiburg, Fac Med, Med Ctr, Dept Med 3,Interdisciplinary Med Intens Care, Hugstetterstr 55, D-79106 Freiburg, Germany Univ Freiburg, Dept Cardiol & Angiol 1, Heart Ctr Freiburg Univ, Fac Med, Freiburg, Germany Univ Freiburg, Fac Med, Med Ctr, Dept Med 3,Interdisciplinary Med Intens Care, Hugstetterstr 55, D-79106 Freiburg, GermanyBode, Christoph论文数: 0 引用数: 0 h-index: 0机构: Univ Freiburg, Fac Med, Med Ctr, Dept Med 3,Interdisciplinary Med Intens Care, Hugstetterstr 55, D-79106 Freiburg, Germany Univ Freiburg, Dept Cardiol & Angiol 1, Heart Ctr Freiburg Univ, Fac Med, Freiburg, Germany Univ Freiburg, Fac Med, Med Ctr, Dept Med 3,Interdisciplinary Med Intens Care, Hugstetterstr 55, D-79106 Freiburg, GermanyStaudacher, Dawid L.论文数: 0 引用数: 0 h-index: 0机构: Univ Freiburg, Fac Med, Med Ctr, Dept Med 3,Interdisciplinary Med Intens Care, Hugstetterstr 55, D-79106 Freiburg, Germany Univ Freiburg, Dept Cardiol & Angiol 1, Heart Ctr Freiburg Univ, Fac Med, Freiburg, Germany Univ Freiburg, Fac Med, Med Ctr, Dept Med 3,Interdisciplinary Med Intens Care, Hugstetterstr 55, D-79106 Freiburg, Germany论文数: 引用数: h-index:机构:
- [29] Randomized clinical trial to evaluate safety and efficacy of convalescent plasma use among hospitalized patients with COVID-19 (PERUCONPLASMA): a structured summary of a study protocol for a randomized controlled trial[J]. Trials, 22Alonso Soto论文数: 0 引用数: 0 h-index: 0机构: Universidad Ricardo Palma,Biomedical Sciences Research Institute, School of MedicineFiorella Krapp论文数: 0 引用数: 0 h-index: 0机构: Universidad Ricardo Palma,Biomedical Sciences Research Institute, School of MedicineAlex Vargas论文数: 0 引用数: 0 h-index: 0机构: Universidad Ricardo Palma,Biomedical Sciences Research Institute, School of MedicineLucía Cabrejos论文数: 0 引用数: 0 h-index: 0机构: Universidad Ricardo Palma,Biomedical Sciences Research Institute, School of MedicineEnrique Argumanis论文数: 0 引用数: 0 h-index: 0机构: Universidad Ricardo Palma,Biomedical Sciences Research Institute, School of MedicinePatricia L. García论文数: 0 引用数: 0 h-index: 0机构: Universidad Ricardo Palma,Biomedical Sciences Research Institute, School of MedicineKarina Altamirano论文数: 0 引用数: 0 h-index: 0机构: Universidad Ricardo Palma,Biomedical Sciences Research Institute, School of MedicineMartín Montes论文数: 0 引用数: 0 h-index: 0机构: Universidad Ricardo Palma,Biomedical Sciences Research Institute, School of MedicinePamela R. Chacón-Uscamaita论文数: 0 引用数: 0 h-index: 0机构: Universidad Ricardo Palma,Biomedical Sciences Research Institute, School of MedicinePatricia J. García论文数: 0 引用数: 0 h-index: 0机构: Universidad Ricardo Palma,Biomedical Sciences Research Institute, School of Medicine
- [30] An adaptive randomised placebo controlled phase II trial of antivirals for COVID-19 infection (VIRCO): A structured summary of a study protocol for a randomised controlled trial[J]. TRIALS, 2020, 21 (01)McMahon, James H.论文数: 0 引用数: 0 h-index: 0机构: Alfred Hosp, Dept Infect Dis, Melbourne, Vic, Australia Monash Univ, Melbourne, Vic, Australia Monash Med Ctr, Dept Infect Dis, Melbourne, Vic, Australia Alfred Hosp, Dept Infect Dis, Melbourne, Vic, AustraliaLau, Jillian S. Y.论文数: 0 引用数: 0 h-index: 0机构: Alfred Hosp, Dept Infect Dis, Melbourne, Vic, Australia Monash Univ, Melbourne, Vic, Australia Eastern Hlth, Dept Infect Dis, Melbourne, Vic, Australia Alfred Hosp, Dept Infect Dis, Melbourne, Vic, AustraliaRoney, Janine论文数: 0 引用数: 0 h-index: 0机构: Alfred Hosp, Dept Infect Dis, Melbourne, Vic, Australia Monash Univ, Melbourne, Vic, Australia Alfred Hosp, Dept Infect Dis, Melbourne, Vic, AustraliaRogers, Benjamin A.论文数: 0 引用数: 0 h-index: 0机构: Monash Med Ctr, Dept Infect Dis, Melbourne, Vic, Australia Alfred Hosp, Dept Infect Dis, Melbourne, Vic, AustraliaTrubiano, Jason论文数: 0 引用数: 0 h-index: 0机构: Austin Hosp, Dept Infect Dis, Melbourne, Vic, Australia Alfred Hosp, Dept Infect Dis, Melbourne, Vic, AustraliaSasadeusz, Joseph论文数: 0 引用数: 0 h-index: 0机构: Royal Melbourne Hosp, Dept Infect Dis, Melbourne, Vic, Australia Alfred Hosp, Dept Infect Dis, Melbourne, Vic, AustraliaMolton, James S.论文数: 0 引用数: 0 h-index: 0机构: Western Hlth, Dept Infect Dis, Melbourne, Vic, Australia Alfred Hosp, Dept Infect Dis, Melbourne, Vic, Australia论文数: 引用数: h-index:机构:Lee, Sue J.论文数: 0 引用数: 0 h-index: 0机构: Alfred Hosp, Dept Infect Dis, Melbourne, Vic, Australia Monash Univ, Melbourne, Vic, Australia Alfred Hosp, Dept Infect Dis, Melbourne, Vic, AustraliaHoy, Jennifer F.论文数: 0 引用数: 0 h-index: 0机构: Alfred Hosp, Dept Infect Dis, Melbourne, Vic, Australia Monash Univ, Melbourne, Vic, Australia Alfred Hosp, Dept Infect Dis, Melbourne, Vic, AustraliaCheng, Allen论文数: 0 引用数: 0 h-index: 0机构: Alfred Hosp, Dept Infect Dis, Melbourne, Vic, Australia Monash Univ, Melbourne, Vic, Australia Alfred Hosp, Dept Infect Dis, Melbourne, Vic, AustraliaPeleg, Anton Y.论文数: 0 引用数: 0 h-index: 0机构: Alfred Hosp, Dept Infect Dis, Melbourne, Vic, Australia Monash Univ, Melbourne, Vic, Australia Alfred Hosp, Dept Infect Dis, Melbourne, Vic, Australia